论文部分内容阅读
目的评价抗郁抑药黛力新与胃粘膜保护剂替普瑞酮联合治疗功能性消化不良的疗效,为临床实践提供证据,并为抗郁抑药治疗功能性消化不良提供进一步的临床研究思路。方法制定严格的纳入和排除标准,本文收集云南省昆明医学院第六附属医院自2012年1月至2012年6月收治的功能性消化不良患者80例。随机分为两组。治疗组40例采用黛力新与替普瑞酮联合治疗,对照组单用替普瑞酮治疗。结果治疗组效果明显优于对照组(P<0.05)。结论黛力新与替普瑞酮联合治疗功能性消化不良有明显疗效。
Objective To evaluate the curative effect of antidote inhibition Deanxit and gastric mucosal protective agent teprenone in the treatment of functional dyspepsia and to provide evidence for clinical practice and to provide further clinical research ideas for antidepressant drug treatment of functional dyspepsia . Methods To establish a strict inclusion and exclusion criteria, this article collected 80 cases of functional dyspepsia patients who were admitted to the Sixth Affiliated Hospital of Kunming Medical College from January 2012 to June 2012. Randomly divided into two groups. Treatment group 40 patients with Deanxit and teprenone combination therapy, the control group treated with teprenone alone. Results The treatment group was significantly better than the control group (P <0.05). Conclusion Deanxit and teprenone combined treatment of functional dyspepsia have a significant effect.